评估乙型肝炎免疫球蛋白(HBIG)与乙型肝炎疫苗同时接种时对疫苗应答的影响
研究在新生和成年BALB/c小鼠中比较单用乙型肝炎疫苗与同时同部位或不同部位给予乙型肝炎免疫球蛋白(HBIG)后的免疫应答。结果显示同时给予HBIG可延迟并降低对乙型肝炎疫苗的应答,但26周加强后HBsAg特异性B细胞扩增和记忆表型未受影响。作者认为初始循环HBIG水平可能预防感染,并支持现有建议:对HBV携带者母亲所生婴儿在完成系列接种后评估血清保护,包括疫苗与HBIG被错误接种于同一部位的情况。
要点
- 小鼠中乙型肝炎疫苗与HBIG同时给予可延迟并降低对疫苗的应答。
- 新生小鼠三剂系列接种结束时抗-HBs水平降低(p<0.0001),无论接种部位。
- 成年小鼠仅在疫苗与HBIG同一部位接种时见差异,26周加强后B细胞记忆未受影响。
核心结论
- 在小鼠中,乙型肝炎疫苗与HBIG同时给予可延迟并降低对乙型肝炎疫苗的应答。
- 作者的发现提示初始循环HBIG水平可能预防感染,尽管对疫苗的应答受损。
- 作者认为这支持当前建议:对HBV携带者母亲所生婴儿在完成系列接种后评估血清保护,包括疫苗与HBIG被错误接种于同一部位的情况。
研究设计与样本
- 研究采用新生和成年BALB/c小鼠,在0时给予一剂乙型肝炎疫苗单用或与HBIG同部位或不同部位同时给予。
- 新生小鼠在3周和10周各追加一剂乙型肝炎疫苗,成年小鼠在4周和16周各追加一剂。
- 为研究记忆应答,小鼠在26周接受第4剂加强乙型肝炎疫苗并分析B细胞。
主要发现
- 与单用乙型肝炎疫苗的小鼠相比,同时给予HBIG在无论接种部位的情况下均导致对乙型肝炎疫苗前两剂后的应答降低。
- 所有接受乙型肝炎疫苗与HBIG的新生小鼠组在三剂系列接种结束时抗-HBs水平较低(p<0.0001)。
- 在成年小鼠中,仅在乙型肝炎疫苗与HBIG同一部位接种时观察到该差异。
- 在26周乙型肝炎疫苗加强后,HBsAg特异性B细胞扩增和记忆表型未受初始HBIG给予的影响。
关键数值与推荐
- 新生小鼠三剂系列接种结束时抗-HBs水平降低的p<0.0001。
临床怎么用
- 作者认为初始循环HBIG水平可能预防感染,尽管对疫苗的应答受损。
- 作者认为这支持当前建议:对HBV携带者母亲所生婴儿在完成系列接种后评估血清保护,包括疫苗与HBIG被错误接种于同一部位的情况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A hepatitis B vaccination (HepB) series with an initial dose of hepatitis B immune globulin (HBIG) is the recommended prophylaxis for infants born to mothers with chronic hepatitis B virus (HBV) infection and for HBV-exposed persons without known protection. The HepB and HBIG are administered at different sites (limbs). Instances of HepB and HBIG administered at the same site are documented but the impact on immune responses to HepB remains unanswered. METHODS: Newborn and adult BALB/c mice received one dose of HepB at time zero alone or with HBIG in the same or different sites, followed by 2 additional doses of HepB at 3 and 10 weeks (newborn mice) or 4 and 16 weeks (adult mice). To study memory responses mice were given a 4th, booster, dose of HepB at 26 weeks and B cells analyzed. RESULTS: Administration of HepB with HBIG resulted in reduced responses to HepB following the first 2 doses, regardless of site, compared to mice that received HepB only. Lower levels of antibody to HBV surface antigen (anti-HBs) were observed at the end of the 3-dose series (p < 0.0001) in all groups of newborn mice that received HepB and HBIG. In adult mice, this difference was only seen when HepB and HBIG were delivered at the same site. However, following a HepB booster at 26 weeks, HBsAg-specific B-cell expansion and memory phenotype were not impacted by initial HBIG administration CONCLUSION: Administration of HBIG with HepB can delay and reduce responses to HepB in mice. Our findings suggest that the initial circulating levels of HBIG could prevent infection despite an impaired response to vaccine and support the current recommendation of assessing seroprotection after series completion for infants born to HBV carrier mothers, including in cases where vaccine and HBIG are administered incorrectly at the same site.
引用
- Zubkova I, Zhao Y, Cui Q, et al. Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine during co-administration. Vaccine. 2022. PMID: 36586740. doi:10.1016/j.vaccine.2022.12.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。